BACE1 and Alzheimer disease: Shown by Figure 1, DNA methylation modulators (such as SAM) can reduce the hypomethylation of the AD-related gene bace-1 and inhibit the pathological aggregation of Aβ, improving cognitive function (Klose and Bird, 2006).